AZITRA INC.
🏢 View company profile →6Patents
6Active
6Granted
43Portfolio score
Filing activity: May 28, 2015 → Oct 5, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10702558B2 | Therapeutic treatment of skin disease with recombinant commensal skin microorganisms | Chemistry; Metallurgy | 2 | Active |
| US11850267B2 | Methods and compositions for treating skin disease with recombinant microorganisms | Chemistry; Metallurgy | 0 | Active |
| US11773154B2 | Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes | Chemistry; Metallurgy | 0 | Active |
| US12036248B2 | Therapeutic treatment of skin disease with recombinant commensal skin microorganisms | Chemistry; Metallurgy | 0 | Active |
| US12208124B2 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | Chemistry; Metallurgy | 0 | Active |
| US11041217B2 | Auxotrophic strains of staphylococcus bacterium | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.